Haemonetics Total Assets 2010-2025 | HAE

Haemonetics total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
Haemonetics Annual Total Assets
(Millions of US $)
2025 $2,451
2024 $2,196
2023 $1,935
2022 $1,860
2021 $1,820
2020 $1,267
2019 $1,275
2018 $1,237
2017 $1,239
2016 $1,319
2015 $1,485
2014 $1,514
2013 $1,462
2012 $911
2011 $833
2010 $761
2009 $650
Haemonetics Quarterly Total Assets
(Millions of US $)
2025-03-31 $2,451
2024-12-31 $2,531
2024-09-30 $2,525
2024-06-30 $2,541
2024-03-31 $2,196
2023-12-31 $2,200
2023-09-30 $2,011
2023-06-30 $1,962
2023-03-31 $1,935
2022-12-31 $1,878
2022-09-30 $1,865
2022-06-30 $1,821
2022-03-31 $1,860
2021-12-31 $1,831
2021-09-30 $1,801
2021-06-30 $1,794
2021-03-31 $1,820
2020-12-31 $1,318
2020-09-30 $1,418
2020-06-30 $1,433
2020-03-31 $1,267
2019-12-31 $1,238
2019-09-30 $1,191
2019-06-30 $1,260
2019-03-31 $1,275
2018-12-31 $1,228
2018-09-30 $1,266
2018-06-30 $1,241
2018-03-31 $1,237
2017-12-31 $1,312
2017-09-30 $1,271
2017-06-30 $1,251
2017-03-31 $1,239
2016-12-31 $1,306
2016-09-30 $1,335
2016-06-30 $1,317
2016-03-31 $1,319
2015-12-31 $1,336
2015-09-30 $1,419
2015-06-30 $1,427
2015-03-31 $1,485
2014-12-31 $1,474
2014-09-30 $1,475
2014-06-30 $1,477
2014-03-31 $1,514
2013-12-31 $1,488
2013-09-30 $1,484
2013-06-30 $1,480
2013-03-31 $1,462
2012-12-31 $1,474
2012-09-30 $1,455
2012-06-30 $928
2012-03-31 $911
2011-12-31 $848
2011-09-30 $824
2011-06-30 $853
2011-03-31 $833
2010-12-31 $783
2010-09-30 $738
2010-06-30 $698
2010-03-31 $761
2009-12-31 $702
2009-09-30 $714
2009-06-30 $692
2009-03-31 $650
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.663B $1.361B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.329B 28.06
Boston Scientific (BSX) United States $153.315B 38.38
Stryker (SYK) United States $149.550B 31.27
EssilorLuxottica (ESLOY) France $129.320B 0.00
Medtronic (MDT) Ireland $113.223B 16.05
Lonza Group Ag (LZAGY) Switzerland $50.710B 0.00
Haleon (HLN) United Kingdom $46.111B 26.31
ResMed (RMD) United States $37.519B 28.18
GE HealthCare Technologies (GEHC) United States $34.854B 16.55
Agilent Technologies (A) United States $34.275B 22.34
Terumo (TRUMY) Japan $25.791B 33.50
Koninklijke Philips (PHG) Netherlands $23.611B 16.57
Insulet (PODD) United States $21.226B 83.32
Zimmer Biomet Holdings (ZBH) United States $18.499B 11.88
Baxter (BAX) United States $15.975B 11.93
Smith & Nephew SNATS (SNN) United Kingdom $13.209B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.821B 23.74
Lantheus Holdings (LNTH) United States $5.509B 13.90
Prestige Consumer Healthcare (PBH) United States $3.962B 17.70
Perrigo (PRGO) Ireland $3.748B 9.50
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.419B 28.41
ICU Medical (ICUI) United States $3.352B 24.72
QuidelOrtho (QDEL) United States $2.041B 14.04
LeMaitre Vascular (LMAT) United States $1.894B 42.35
AtriCure (ATRC) United States $1.554B 0.00
Acuren (TIC) United States $1.375B 0.00
AdaptHealth (AHCO) United States $1.264B 12.84
Green Thumb Industries (GTBIF) United States $1.169B 26.29
Neogen (NEOG) United States $1.135B 14.53
Phibro Animal Health (PAHC) United States $1.133B 14.48
BioLife Solutions (BLFS) United States $1.081B 0.00
InMode (INMD) Israel $0.961B 9.69
Kestra Medical Technologies (KMTS) United States $0.783B 0.00
Owens & Minor (OMI) United States $0.718B 5.96
Maravai LifeSciences Holdings (MRVI) United States $0.675B 0.00
CeriBell (CBLL) United States $0.673B 0.00
Evolus (EOLS) United States $0.594B 0.00
Curaleaf Holdings (CURLF) Canada $0.551B 0.00
Valneva SE (VALN) France $0.494B 0.00
Tilray Brands (TLRY) Canada $0.488B 0.00
Capricor Therapeutics (CAPR) United States $0.458B 0.00
Surmodics (SRDX) United States $0.415B 0.00
VAREX IMAGING (VREX) United States $0.359B 13.21
Quanterix (QTRX) United States $0.346B 0.00
SNDL (SNDL) Canada $0.328B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.301B 0.00
Cerus (CERS) United States $0.298B 0.00
Viemed Healthcare (VMD) United States $0.280B 23.60
ZimVie (ZIMV) United States $0.279B 12.67
Sanuwave Health (SNWV) United States $0.271B 0.00
Sanara MedTech (SMTI) United States $0.266B 0.00
Aurora Cannabis (ACB) Canada $0.251B 74.50
Cresco Labs (CRLBF) United States $0.251B 0.00
Brainsway (BWAY) Israel $0.242B 64.00
Biote (BTMD) United States $0.229B 6.45
OraSure Technologies (OSUR) United States $0.229B 0.00
Canopy Growth (CGC) Canada $0.219B 0.00
High Tide (HITI) Canada $0.190B 0.00
Utah Medical Products (UTMD) United States $0.187B 15.21
TriSalus Life Sciences (TLSI) United States $0.185B 0.00
Organigram Global (OGI) Canada $0.185B 0.00
Verano Holdings (VRNOF) United States $0.182B 0.00
Omeros (OMER) United States $0.181B 0.00
Vireo Growth (VREOF) United States $0.150B 0.00
Exagen (XGN) United States $0.148B 0.00
FitLife Brands (FTLF) United States $0.128B 15.73
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.096B 12.33
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
MacroGenics (MGNX) United States $0.087B 0.00
TerrAscend (TSNDF) Canada $0.086B 0.00
Veru (VERU) United States $0.086B 0.00
Zynex (ZYXI) United States $0.081B 0.00
Apyx Medical (APYX) United States $0.081B 0.00
Quipt Home Medical (QIPT) United States $0.077B 0.00
Agape ATP (ATPC) $0.069B 0.00
InterCure (INCR) Israel $0.067B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
Jushi Holdings (JUSHF) United States $0.060B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
Nephros (NEPH) United States $0.042B 56.86
Modular Medical (MODD) United States $0.038B 0.00
United-Guardian (UG) United States $0.037B 12.81
Safety Shot (SHOT) United States $0.030B 0.00
Rockwell Medical (RMTI) United States $0.028B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
INLIF (INLF) $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Senestech (SNES) United States $0.011B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00